Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

KDP

Unveiling the Momentum Driving Keurig Dr Pepper Stocks.

Keurig Dr Pepper stock is trading -7.8% below its average target price of $38.6 after marking a 1.2% during today's morning session. Analysts are giving the Large-Cap Beverages company an average rating of buy and target prices ranging from $34.0 to $42.0 per share.

The stock has an average amount of shares sold short at 2.3%, and a short ratio of 2.6. The company's insiders own 4.96% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 95.4% of Keurig Dr Pepper's shares being owned by this investor type.

Institutions Invested in Keurig Dr Pepper

Date Reported Holder Percentage Shares Value
2025-06-30 Vanguard Group Inc 11% 159,257,574 $5,666,384,774
2025-06-30 Capital World Investors 9% 130,527,385 $4,644,164,597
2025-06-30 Blackrock Inc. 8% 113,516,516 $4,038,917,847
2025-06-30 FMR, LLC 8% 106,828,977 $3,800,975,197
2025-06-30 JPMORGAN CHASE & CO 5% 68,991,045 $2,454,701,507
2025-06-30 State Street Corporation 5% 63,608,006 $2,263,172,969
2025-06-30 Wellington Management Group, LLP 4% 50,965,529 $1,813,353,615
2025-06-30 Harris Associates L.P. 3% 47,118,176 $1,676,464,788
2025-06-30 Invesco Ltd. 2% 31,467,631 $1,119,618,368
2025-06-30 Geode Capital Management, LLC 2% 30,217,363 $1,075,133,830

Besides an analyst consensus of some upside potential, other market factors point to there being positive market sentiment on Keurig Dr Pepper.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS